Nucleotide

Curated by Signal

Online platform for NGS sequence analytics

Overview

Nucleotidy offers an online platform for NGS sequence analysis. The Nucleotidy.bio is a cloud-based platform for storing and accessing NGS data. The company is also developing a smartphone connected portable sequencer for obtaining the data, storing on the cloud and analyzing using the platform.

Key facts

Founded: 2019
Headquarters: Germany
Stage: Sign up to view
Industry: Life Sciences Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Biobase
Provider of commercial biological databases for gene expression, pathway, and NGS analysis
Life Sciences TechnologyWolfenbuttel, Germany
LION Bioscience
Provider of bioinformatics and cheminformatics software products and solution
Life Sciences TechnologyHeidelberg, Germany
Medset Medizintechnik
Portfolio of devices and tools for cardio-pulmonary function diagnostics
Life Sciences TechnologyHamburg, Germany

About Nucleotide

What does Nucleotide do?

Nucleotidy offers an online platform for NGS sequence analysis.

Where is Nucleotide headquartered?

Nucleotide is headquartered in Germany.

When was Nucleotide founded?

Nucleotide was founded in 2019.

Which sector is Nucleotide in?

Nucleotide operates in Life Sciences Technology.

Who are Nucleotide's competitors?

Companies similar to Nucleotide include Biobase, LION Bioscience, and Medset Medizintechnik.